Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an AUA/ASTRO/SUO Guideline Summary-Reference-Cited by-同舟云学术

Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an AUA/ASTRO/SUO Guideline Summary

Published:2018-10 Issue:10 Volume:14 Page:618-624
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Bekelman Justin E.¹,Rumble R. Bryan¹,Freedland Stephen J.¹

Affiliation:

1. University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; American Society of Clinical Oncology, Alexandria, VA; Cedars-Sinai Medical Center, Los Angeles, CA; and Durham Veterans Affairs Medical Center, Durham, NC

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology(nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.18.00434

Reference4 articles.

1. Cancer statistics, 2018

2. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

3. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical efficacy of a rehabilitation management protocol for urinary incontinence after robot-assisted laparoscopic prostatectomy;Supportive Care in Cancer;2024-09-11

2. Clinical efficacy of a rehabilitation management protocol for urinary incontinence after robot-assisted laparoscopic prostatectomy;2024-06-04

3. Effect of preoperative PI-RADS assessment on pathological outcomes in patients who underwent radical prostatectomy;Cancer Imaging;2023-11-26

4. Patterns of multispecialty care for low- and intermediate-risk prostate cancer in the use of active surveillance;Urologic Oncology: Seminars and Original Investigations;2023-09

5. Use of expectant management based on prostate cancer risk and health status: How far are we from a risk-adapted approach?;Urologic Oncology: Seminars and Original Investigations;2023-07